Pac Premier
Giving Guide
You are here:  Home  >  'Erelzi'

FDA approves biosimilar of Amgen’s Enbrel

By   /  Tuesday, August 30th, 2016  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on FDA approves biosimilar of Amgen’s Enbrel

The U.S. Food and Drug Administration formally approved a competing biosimilar of Amgen’s top-selling drug Enbrel on Aug. 30. Made by Switzerland-based Novartis, Erelzi mimics the effects of Enbrel. Enbrel, which was first approved in 1998, is approved to treat rheumatoid arthritis and other conditions by decreasing the amount of a protein produced by the Read More →

Read More →